MS
Moringa Sponsor, LP disclosed a 17.7% stake in SLXN
Moringa Sponsor, LP reported owning 17.7% of Silexion Therapeutics Corp (SLXN) (1,954,056 shares) in a Schedule 13D filed Sep 28, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Sep 28, 2026
- Source
- Schedule 13D